1. Known hypersensitivity to any of the ingredients of the study drug <br/ >2. Pregnant and lactating women <br/ >3. Children <18 yrs. of age, elderly >75 years <br/ >4. SpO2 <90% for adults and respiratory rate >30/minute <br/ >5. Known history of gout or hyperuricemia (serum uric acid level >8 mg/dl), <br/ >urolithiasis, nephrolithiasis or any degree of renal dysfunction <br/ >6. Patients with history of diagnosed primary congenital immunodeficiency, or <br/ >acquired immunodeficiency like HIV, OR any Genetic or developmental anomaly <br/ >like Cerebral Palsy, coeliac disease, lactose intolerant, cancer in nor remission <br/ >stage. <br/ >7. Patient who are undergoing treatment with xanthine oxidase inhibitors, uricosuric <br/ >agents, diuretics, immunosuppressive agents or zidovudine. <br/ >8. Patients with severe cardiac, hepatic, gastrointestinal, renal, pulmonary and skin <br/ >diseases. <br/ >9. Patients simultaneously participating in another clinical study. <br/ >10. Medical or psychological conditions deemed by the investigators to interfere with <br/ >successful participation in the study <br/ >11. A subject who is judged by the investigator as inappropriate to participate in the <br/ >study for any reason other than those mentioned above.

1. Known hypersensitivity to any of the ingredients of the study drug <br/ >2. Pregnant and lactating women <br/ >3. Children <18 yrs. of age, elderly >75 years <br/ >4. SpO2 <90% for adults and respiratory rate >30/minute <br/ >5. Known history of gout or hyperuricemia (serum uric acid level >8 mg/dl), <br/ >urolithiasis, nephrolithiasis or any degree of renal dysfunction <br/ >6. Patients with history of diagnosed primary congenital immunodeficiency, or <br/ >acquired immunodeficiency like HIV, OR any Genetic or developmental anomaly <br/ >like Cerebral Palsy, coeliac disease, lactose intolerant, cancer in nor remission <br/ >stage. <br/ >7. Patient who are undergoing treatment with xanthine oxidase inhibitors, uricosuric <br/ >agents, diuretics, immunosuppressive agents or zidovudine. <br/ >8. Patients with severe cardiac, hepatic, gastrointestinal, renal, pulmonary and skin <br/ >diseases. <br/ >9. Patients simultaneously participating in another clinical study. <br/ >10. Medical or psychological conditions deemed by the investigators to interfere with <br/ >successful participation in the study <br/ >11. A subject who is judged by the investigator as inappropriate to participate in the <br/ >study for any reason other than those mentioned above.

N/A

N/A

1. Known hypersensitivity to any of the ingredients of the study drug <br/ >2. Pregnant and lactating women <br/ >3. Children <18 yrs. of age, elderly >75 years <br/ >4. SpO2 <90% for adults and respiratory rate >30/minute <br/ >5. Known history of gout or hyperuricemia (serum uric acid level >6 mg/dl), urolithiasis, nephrolithiasis or any degree of renal dysfunction <br/ >6. Patients with history of diagnosed primary congenital immunodeficiency, or acquired immunodeficiency like HIV, OR any Genetic or developmental anomaly like Cerebral Palsy, coeliac disease, lactose intolerant, cancer in nor remission stage. <br/ >7. Patient who are undergoing treatment with xanthine oxidase inhibitors, uricosuric agents, diuretics, immunosuppressive agents or zidovudine. <br/ >8. Patients with severe cardiac, hepatic, gastrointestinal, renal, pulmonary and skin diseases. <br/ >9. Patients simultaneously participating in another clinical study. <br/ >10. Medical or psychological conditions deemed by the investigators to interfere with successful participation in the study <br/ >11. A subject who is judged by the investigator as inappropriate to participate in the study for any reason other than those mentioned above.

1. Known hypersensitivity to any of the ingredients of the study drug <br/ >2. Pregnant and lactating women <br/ >3. Children <18 yrs. of age, elderly >75 years <br/ >4. SpO2 <90% for adults and respiratory rate >30/minute <br/ >5. Known history of gout or hyperuricemia (serum uric acid level >6 mg/dl), urolithiasis, nephrolithiasis or any degree of renal dysfunction <br/ >6. Patients with history of diagnosed primary congenital immunodeficiency, or acquired immunodeficiency like HIV, OR any Genetic or developmental anomaly like Cerebral Palsy, coeliac disease, lactose intolerant, cancer in nor remission stage. <br/ >7. Patient who are undergoing treatment with xanthine oxidase inhibitors, uricosuric agents, diuretics, immunosuppressive agents or zidovudine. <br/ >8. Patients with severe cardiac, hepatic, gastrointestinal, renal, pulmonary and skin diseases. <br/ >9. Patients simultaneously participating in another clinical study. <br/ >10. Medical or psychological conditions deemed by the investigators to interfere with successful participation in the study <br/ >11. A subject who is judged by the investigator as inappropriate to participate in the study for any reason other than those mentioned above.